ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin.
Year: 2002
Type: article
Source: PubMed
Authors: Vicki Smith, Stephen Hobbs, William Court, Suzanne Eccles, Paul Workman, Lloyd R Kelland
Institution: Institute of Cancer Research
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W152925858
